Russell Barton Acumen Pharmaceuticals, Inc. (ABOS) insider trading activity

ABOS Quotes by TradingView

Russell Barton is Chief Operating Officer of Acumen Pharmaceuticals, Inc.. Currently has a direct ownership of 136,117 shares of ABOS, which is worth approximately $187,841. The most recent transaction as insider was on Jan 21, 2025, when has been sold 2,914 shares (Common Stock) at a price of $1.61 per share, resulting in proceeds of $4,691. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 136K
40.52% 3M change
40.52% 12M change
Total Value Held $187,841

Russell Barton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 21 2025
SELL
Open market or private sale
$4,691 $1.61 p/Share
2,914 Reduced 2.1%
136,117 Common Stock
Jan 06 2025
BUY
Grant, award, or other acquisition
-
49,800 Added 26.37%
139,031 Common Stock
Jan 03 2025
SELL
Open market or private sale
$14,202 $1.86 p/Share
7,636 Reduced 7.88%
89,231 Common Stock
Jan 18 2024
SELL
Open market or private sale
$10,567 $3.73 p/Share
2,833 Reduced 2.84%
96,867 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
73,000 Added 42.27%
99,700 Common Stock
Jan 17 2023
BUY
Grant, award, or other acquisition
-
26,700 Added 50.0%
26,700 Common Stock
RB

Russell Barton

Chief Operating Officer
Charlottesville, VA

Track Institutional and Insider Activities on ABOS

Follow Acumen Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABOS shares.

Notify only if

Insider Trading

Get notified when an Acumen Pharmaceuticals, Inc. insider buys or sells ABOS shares.

Notify only if

News

Receive news related to Acumen Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ABOS